Your browser doesn't support javascript.
loading
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
van der Sijde, Fleur; Homs, Marjolein Y V; van Bekkum, Marlies L; van den Bosch, Thierry P P; Bosscha, Koop; Besselink, Marc G; Bonsing, Bert A; de Groot, Jan Willem B; Karsten, Thomas M; Groot Koerkamp, Bas; Haberkorn, Brigitte C M; Luelmo, Saskia A C; Mekenkamp, Leonie J M; Mustafa, Dana A M; Wilmink, Johanna W; van Eijck, Casper H J; Vietsch, Eveline E.
Afiliación
  • van der Sijde F; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • van Bekkum ML; Department of Medical Oncology, Reinier de Graaf Gasthuis, 2625 AD Delft, The Netherlands.
  • van den Bosch TPP; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • Bosscha K; Department of Surgery, Jeroen Bosch Hospital, 5223 GZ 's Hertogenbosch, The Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • de Groot JWB; Isala Oncology Center, Isala Hospital, 8025 AB Zwolle, The Netherlands.
  • Karsten TM; Department of Surgery, Onze Lieve Vrouwe Gasthuis, 1061 AE Amsterdam, The Netherlands.
  • Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands.
  • Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, 7512 KZ Enschede, The Netherlands.
  • Mustafa DAM; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
  • Vietsch EE; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
Int J Mol Sci ; 22(20)2021 Oct 09.
Article en En | MEDLINE | ID: mdl-34681562
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / MicroARNs Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / MicroARNs Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos